Brief: Leqembi® Q3 Revenue Totaled Jpy 10 Billion
Oct 30 (Reuters) - BioArctic AB BIOAb.ST :
* LEQEMBI® REVENUE TOTALED JPY 10 BILLION IN THE THIRD
QUARTER
2024
* BIOARCTIC'S PARTNER EISAI TODAY PUBLISHED PRELIM GLOBAL
REVENUE
FOR LEQEMBI DURING Q3 2024, IN CONJUNCTION WITH THEIR PARTNER
BIOGEN'S QUARTERLY REPORT
Source text: ID:nWkr7TwdQp
Further company coverage: BIOAb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million